Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Prognosis of esophageal cancer is poor despite curative surgery. The chemokine receptor CXCR4 has been proposed to distinctly contribute to tumor growth, dissemination and local immune escape in a limited number of malignancies. The...
Main Authors: | Domeyer Mario, von Langsdorff Christian, Drescher Daniel, Frerichs K, Wehler T, Heinrich Christian, Schimanski Carl C, Gockel Ines, Biesterfeld Stefan, Galle Peter R, Junginger Theodor, Moehler Markus |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/290 |
Similar Items
-
Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study
by: Sgourakis George, et al.
Published: (2012-02-01) -
Developments in esophageal surgery for adenocarcinoma: a comparison of two decades
by: Goenner U, et al.
Published: (2007-06-01) -
Morbidity and mortality after esophagectomy for esophageal carcinoma: A risk analysis
by: Exner Christoph, et al.
Published: (2005-06-01) -
Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space
by: Konerding Moritz A, et al.
Published: (2007-04-01) -
Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
by: Stephanie J Gros, et al.
Published: (2012-01-01)